Telesis Bio, Inc.
NASDAQ:TBIO
1.11 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Telesis Bio, Inc. |
Symbool | TBIO |
Munteenheid | USD |
Prijs | 1.11 |
Beurswaarde | 1,967,975 |
Dividendpercentage | 0% |
52-weken bereik | 1.11 - 15.462 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Todd R. Nelson MBA, Ph.D. |
Website | https://codexdna.com |
An error occurred while fetching data.
Over Telesis Bio, Inc.
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)